Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases

Since the early descriptions of sickle cell anemia, it has been clear that genotype at a single locus rarely completely predicts phenotype. This paper reviews explanations for phenotypic variability in some monogenic diseases. In cystic fibrosis, there is strong correlation between genotype and pancreatic phenotype but only weak association with respiratory phenotype, possibly due to differential inheritance of alleles at loci controlling susceptibility to respiratory infection. In addition, disease mutations have been shown to have more or less severe effect, depending on other variation within the cystic fibrosis gene. In phenylketonuria, genotype at the phenylalanine hydroxylase locus appears to explain the biochemical phenotype, but not the intellectual status. There may be genetically determined variation in flux through the minor metabolic pathways for phenylalanine, influencing levels of alternative metabolites involved in mental development. Phenotypic discordance in sickle cell anemia and β‐thalassemia has been associated with the co‐inheritance of genes for hereditary persistence of fetal hemoglobin. A mouse locus has been identified that influences tumour number in mice with the multiple intestinal neoplasia gene. Understanding of the genetic interactions that determine phenotype in apparently monogenic diseases should lead to clarification of the role of different genes in polygenic diseases with complex inheritance patterns, as well as enhancing the ability to predict the outcome of a disease mutation. © 1996 Wiley‐Liss, Inc.

[1]  B. Kerem,et al.  Genotype‐phenotype correlations in cystic fibrosis , 1996, Pediatric pulmonology.

[2]  J. Witte,et al.  Genetic dissection of complex traits. , 1994, Nature genetics.

[3]  G. Lathrop,et al.  Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach , 1996, Nature Genetics.

[4]  L. Tsui,et al.  Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia , 1995, The Lancet.

[5]  Arthur M Buchberg,et al.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.

[6]  S. Orkin,et al.  Lethal β-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF , 1995, Nature.

[7]  F. Grosveld,et al.  Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene , 1995, Nature.

[8]  R. Kelley,et al.  Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. , 1995, American journal of medical genetics.

[9]  P. Gros,et al.  Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. , 1995, American journal of human genetics.

[10]  M. Faerman,et al.  Sequence analysis reveals a β–thalassaemia mutation in the DNA of skeletal remains from the archaeological site of Akhziv, Israel , 1995, Nature Genetics.

[11]  G. Velho,et al.  A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus , 1995, Nature Genetics.

[12]  W. Rutter,et al.  The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription , 1995, Nature Genetics.

[13]  J. Todd,et al.  Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus , 1995, Nature Genetics.

[14]  G. Novelli,et al.  Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. , 1995, American journal of human genetics.

[15]  A. Chapelle,et al.  Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability , 1995, Nature Genetics.

[16]  P. Modrich,et al.  Mismatch repair, genetic stability, and cancer. , 1994, Science.

[17]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[18]  H. Dietz,et al.  A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. , 1994, The New England journal of medicine.

[19]  B. Kerem,et al.  Correlation between genotype and phenotype in patients with cystic fibrosis. , 1994, The New England journal of medicine.

[20]  A. Cao 1993 William Allan award address. , 1994, American journal of human genetics.

[21]  G. Lathrop,et al.  Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. , 1994, American journal of human genetics.

[22]  C. P. Morris,et al.  Mutation analysis of 28 Gaucher disease patients: the Australasian experience. , 1994, American journal of medical genetics.

[23]  J. Amos,et al.  The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. , 1994, Journal of andrology.

[24]  E. Lander,et al.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.

[25]  M. Gentile,et al.  Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP) , 1993, American journal of human genetics.

[26]  L. Tsui,et al.  A mutation in CFTR produces different phenotypes depending on chromosomal background , 1993, Nature Genetics.

[27]  A. Lindblom,et al.  Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer , 1993, Nature Genetics.

[28]  S. Milstien,et al.  Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. , 1993, American journal of human genetics.

[29]  Riccardi Vm Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1) , 1993 .

[30]  E. Nieschlag,et al.  Compound heterozygosity for the delta F508 and F508C cystic fibrosis transmembrane conductance regulator (CFTR) mutations in a patient with congenital bilateral aplasia of the vas deferens. , 1993, American journal of human genetics.

[31]  C. Eng,et al.  Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. , 1993, American journal of human genetics.

[32]  J. Weber,et al.  Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.

[33]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[34]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[35]  S. Forrest,et al.  Comparison of genotype and intellectual phenotype in untreated PKU patients. , 1993, Journal of medical genetics.

[36]  Johanna M. Rommens,et al.  The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR , 1993, Nature Genetics.

[37]  J. Beckmann,et al.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.

[38]  M. Robertson,et al.  Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis. , 1993, American journal of human genetics.

[39]  B. Tümmler,et al.  Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis , 1993, The Lancet.

[40]  C. Boeck Correlation between genotype and phenotype in patients with cystic fibrosis , 1993 .

[41]  D. Cox,et al.  DNA markers for the diagnosis of Wilson disease. , 1993, Journal of hepatology.

[42]  M. Macek,et al.  Missense variations in the cystic fibrosis gene: heteroduplex formation in the F508C mutation. , 1992, American journal of human genetics.

[43]  T. Kurtz,et al.  Gene mapping in experimental hypertension. , 1992, Journal of the American Society of Nephrology : JASN.

[44]  L. Abel,et al.  Segregation analysis detects a major gene controlling blood infection levels in human malaria. , 1992, American journal of human genetics.

[45]  M. Corey,et al.  Genetic determination of exocrine pancreatic function in cystic fibrosis. , 1992, American journal of human genetics.

[46]  K. Kinzler,et al.  Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[47]  J. Chalk,et al.  Spasticity and white matter abnormalities in adult phenylketonuria. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[48]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[49]  M. White,et al.  Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. , 1992 .

[50]  J. Gordon,et al.  The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system , 1992, The Journal of cell biology.

[51]  S. Woo,et al.  Molecular basis of phenylketonuria and related hyperphenylalaninemias: Mutations and polymorphisms in the human phenylalanine hydroxylase gene , 1992, Human mutation.

[52]  T. Dörk,et al.  A cystic fibrosis allele encoding missense mutations in both nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator , 1992, Human mutation.

[53]  T. Smyrk,et al.  Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. , 1992, American journal of human genetics.

[54]  R. Williams Key concepts regarding the genetics of hypertension in humans. , 1991, American journal of hypertension.

[55]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[56]  J. McPherson,et al.  Identification of deletion mutations and three new genes at the familial polyposis locus , 1991, Cell.

[57]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[58]  Y. Shiloh,et al.  Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria. , 1991, American journal of human genetics.

[59]  F. Güttler,et al.  Molecular basis of phenotypic heterogeneity in phenylketonuria. , 1991, The New England journal of medicine.

[60]  R. Elston,et al.  Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: application to traits related to hypertension. , 1991, American journal of human genetics.

[61]  J. Groffen,et al.  Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes. , 1991, American journal of human genetics.

[62]  J. Boué,et al.  The ΔF508 mutation in mild adult forms of cystic fibrosis (CF) , 1991 .

[63]  D Markiewicz,et al.  The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). , 1990, The New England journal of medicine.

[64]  M. Hodson,et al.  Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis , 1990, The Lancet.

[65]  A. Beaudet,et al.  Benign missense variations in the cystic fibrosis gene. , 1990, American journal of human genetics.

[66]  Philippe Roussel,et al.  Abnormal distribution of CF ΔF508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens , 1990, The Lancet.

[67]  R. Rozen,et al.  Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. , 1990, American journal of human genetics.

[68]  D. Malo,et al.  Immunogenetics of mycobacterial infections: mouse-human homologies. , 1990, The Journal of infectious diseases.

[69]  J M Lalouel,et al.  Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. , 1990, The New England journal of medicine.

[70]  K. Aalto-Setälä,et al.  Molecular genetics of hypercholesterolemia. , 1990, Annals of medicine.

[71]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[72]  S C Hunt,et al.  Current knowledge regarding the genetics of human hypertension. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[73]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[74]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[75]  M. Corey,et al.  Familial concordance of pancreatic function in cystic fibrosis. , 1989, The Journal of pediatrics.

[76]  A. Schechter,et al.  Intracellular Polymerization , 1989, Annals of the New York Academy of Sciences.

[77]  G. Saglio,et al.  A benign form of thalassaemia intermedia may be determined by the interaction of triplicated α locus and heterozygous β‐thalassaemia , 1987 .

[78]  J. Wainscoat,et al.  Thalassaemia intermedia: interaction of the triple α‐globin gene arrangement and heterozygous β‐thalassaemia , 1987 .

[79]  F. Ledley,et al.  Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders. , 1986, The New England journal of medicine.

[80]  A. Hoffbrand,et al.  Thalassaemia intermedia: a new molecular basis , 1984, British journal of haematology.

[81]  W. Wood,et al.  The triplicated α gene locus and β thalassaemia , 1983 .

[82]  E. Kanavakis,et al.  The triplicated alpha gene locus and beta thalassaemia. , 1983, British journal of haematology.

[83]  A. Cao,et al.  Alpha globin gene analysis in a Sardinian family with interacting alpha and beta thalassaemia genes , 1983, British journal of haematology.

[84]  J. Clegg,et al.  Thalassaemia intermedia in Cyprus: the interaction of alpha and beta thalassaemia. , 1983 .

[85]  J. Clegg,et al.  Thalassaemia intermedia in Cyprus: the interaction of α and β thalassaemia , 1983, British journal of haematology.

[86]  D. Weatherall,et al.  The interaction of α thalassaemia with heterozygous β thalassaemia , 1982, British journal of haematology.

[87]  Julian R. E. Davis,et al.  Concurrent Sickle-Cell Anemia and α-Thalassemia: Effect on Severity of Anemia , 1982 .

[88]  A. Schechter,et al.  What determines severity in sickle-cell disease? , 1982, The New England journal of medicine.

[89]  P. Gros,et al.  Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. , 1981, Journal of immunology.

[90]  M. Cappellini,et al.  Interaction between Homozygous β0 Thalassaemia and the Swiss Type of Hereditary Persistence of Fetal Haemoglobin , 1981, British journal of haematology.

[91]  V. McKusick,et al.  The Marfan syndrome: diagnosis and management. , 1979, The New England journal of medicine.

[92]  T. Necheles,et al.  Mild sickle cell disease. Clinical and laboratory studies. , 1973, JAMA.

[93]  H. Ranney Interactions of other hemoglobin variants with sickle-cell hemoglobin. , 1970, The New England journal of medicine.